Evidence map›Paper›PMID 41204005›Full record

ReviewSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025

Taste disorders in cancer patients and current therapeutic approaches: a narrative review of an understudied topic in supportive care.

Andrei Barasch, Joel B Epstein

Abstract readReview
PubMed Publisher
In one paragraph

Review in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Andrei BaraschHarvard School of Dental Medicine, Boston, MA, USA. Abarasch218@gmail.com.
Joel B EpsteinOral Health Services, Division of Head and Neck Surgery, Duarte, City of Hope, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite being among the most common cancer treatment-related side effects, taste disorders have received limited study, and their management remains challenging. Recent data have associated dysgeusia with decreased quality of life and increased mortality. We discuss here the state of the science on this topic and address clinical concerns and understudied therapeutics, with the aim of stressing the importance of this side effect and the need for effective treatment.

methodsWe selected extant articles covering cancer therapy-associated dysgeusia in English language peer-reviewed literature from PubMed, Medline, Cochrane Library, and Scopus databases. We identified 368 articles, of which 92 were reviewed in detail. The relevant publications have described heterogeneous populations and a multitude of clinical characteristics. The mechanisms of altered taste perception in cancer populations have not been completely elucidated, which in turn has impaired the development of potential interventions, including prevention and management.

conclusionDysgeusia in cancer patients may be more relevant to treatment success and quality of life than previously accepted. Unfortunately, this topic has not been adequately addressed and requires further study.

Indexed as

Antineoplastic AgentsDysgeusiaNeoplasmsTaste DisordersHumansQuality of LifeAntineoplastic AgentsCancer therapyDysgeusiaPreventionTreatment

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.